SI2662093T1 - Tobramycin formulation - Google Patents

Tobramycin formulation

Info

Publication number: SI2662093T1
Authority: SI; Slovenia
Prior art keywords: tobramycin formulation; tobramycin; formulation
Prior art date: 2012-05-09

Application number

SI201330018T

Other languages

Slovenian (sl)

Inventor

David Higham

Kevin Hawkins

Original Assignee

Norton Healthcare Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-05-09

Filing date

2013-04-18

Publication date

2015-06-30

2013-04-18 Application filed by Norton Healthcare Limited filed Critical Norton Healthcare Limited

2013-04-18 Priority claimed from EP13002039.9A external-priority patent/EP2662093B1/en

2015-06-30 Publication of SI2662093T1 publication Critical patent/SI2662093T1/en

Links

SI201330018T 2012-05-09 2013-04-18 Tobramycin formulation SI2662093T1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201261644700P	2012-05-09	2012-05-09
EP13002039.9A EP2662093B1 (en)	2012-05-09	2013-04-18	Tobramycin formulation

Publications (1)

Publication Number	Publication Date
SI2662093T1 true SI2662093T1 (en)	2015-06-30

Family

ID=52594985

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI201330018T SI2662093T1 (en)	2012-05-09	2013-04-18	Tobramycin formulation

Country Status (5)

Country	Link
CY (1)	CY1116053T1 (en)
ES (1)	ES2530751T3 (en)
HR (1)	HRP20150085T1 (en)
RS (1)	RS53878B1 (en)
SI (1)	SI2662093T1 (en)

2013
- 2013-04-18 SI SI201330018T patent/SI2662093T1/en unknown
- 2013-04-18 ES ES13002039T patent/ES2530751T3/en active Active
- 2013-04-18 RS RS20150059A patent/RS53878B1/en unknown
2015
- 2015-01-22 HR HRP20150085TT patent/HRP20150085T1/en unknown
- 2015-02-05 CY CY20151100118T patent/CY1116053T1/en unknown

Also Published As

Publication number	Publication date
HRP20150085T1 (en)	2015-05-08
RS53878B1 (en)	2015-08-31
ES2530751T3 (en)	2015-03-05
CY1116053T1 (en)	2017-02-08

Similar Documents

Publication	Publication Date	Title
HK1203146A1 (en)	2015-10-23	Antibody formulation
PL2802209T3 (en)	2021-07-05	Otic formulations
GB201217441D0 (en)	2012-11-14	Composition
GB201200707D0 (en)	2012-02-29	Composition
HK1202445A1 (en)	2015-10-02	New formulation
ZA201306000B (en)	2014-04-30	Stable formulation
EP2878295A4 (en)	2015-12-23	Composition
GB201218954D0 (en)	2012-12-05	Composition
GB201219657D0 (en)	2012-12-12	Composition
GB201206035D0 (en)	2012-05-16	Composition
PT2662093E (en)	2015-02-17	Tobramycin formulation
EP2910537A4 (en)	2016-06-29	Gas-generating-agent composition
GB201209597D0 (en)	2012-07-11	Composition
GB201208133D0 (en)	2012-06-20	Composition
HK1206989A1 (en)	2016-01-22	Encapsulated formulation
GB201219383D0 (en)	2012-12-12	Composition
GB201218195D0 (en)	2012-11-21	Composition
SI2662093T1 (en)	2015-06-30	Tobramycin formulation
GB201211247D0 (en)	2012-08-08	Improved formulation
GB201220595D0 (en)	2013-01-02	Keysafe application
AU2012905439A0 (en)	2013-01-10	Formulation
AU2012905410A0 (en)	2013-01-10	Formulation
GB201222922D0 (en)	2013-01-30	Topical formulation
GB201220838D0 (en)	2013-01-02	Composition
GB201206178D0 (en)	2012-05-23	Formulations